Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses —63.57 K1.64 M— — Research & development ———— — Operating income —-63.57 K-1.64 M— — Non-Operating Income, Total —1 8641.25 M— — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses —1 8641.25 M— — Unusual income/expense ———— — Pretax income —-61.71 K-395.37 K— — Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations —-61.71 K-395.37 K— — Discontinued operations ———— — Net income —-61.71 K-395.37 K— — Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders —92.13 K395.37 K— — Basic earnings per share (Basic EPS) —0.120.12— — Diluted earnings per share (Diluted EPS) —0.120.12— — Average basic shares outstanding 5 M10.31 M26.3 M32.62 M 74.23 M Diluted shares outstanding 5 M11.8 M27.14 M33.06 M 77 M EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —